Market share in APAC of MS treatments Japan 2017-2028
In 2022, multiple sclerosis (MS) treatments performed in Japan had a market share of about 14.5 percent in the Asia Pacific region. The market share showed a gradual increase since 2017 and was forecast to reach nearly 16.6 percent by 2028.